An2 Therapeutics Share Price Today
(NASDAQ: ANTX)

Name: An2 Therapeutics Share Price (NASDAQ: ANTX) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

An2 Therapeutics share price is $1.2 & ₹101.26 as on 3 May 2025, 2.30 'hrs' IST

$1.2

▲

-0.04

(-3.23%)

Market is closed - opens 7 PM, 05 May 2025

View live An2 Therapeutics share price in Dollar and Rupees. Guide to invest in An2 Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in An2 Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

An2 Therapeutics share price movements

Today's Low: $1.19
Today's High: $1.22
$1.20
1.25%
Downside
Day's Volatility :2.87%
Upside
1.64%
52 Weeks Low: $0.87
52 Weeks High: $3.07
$1.20
27.5%
Downside
52 Weeks Volatility :71.66%
Upside
60.91%

An2 Therapeutics (ANTX) Returns

Period	An2 Therapeutics, Inc.	Index (Russel 2000)
3 Months	10.09%	0.0%
6 Months	11.11%	0.0%
1 Year	-53.67%	0.0%
3 Years	-93.42%	-9.3%

An2 Therapeutics (ANTX) Key Statistics

in dollars & INR

Previous Close	$1.24
Open	$1.19
Today's High	$1.22
Today's Low	$1.185
Market Capitalization	$37.3M
Today's Volume	$201.7K
52 Week High	$3.07
52 Week Low	$0.87
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-1.72
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-49.69%

How to invest in An2 Therapeutics Stock (ANTX) from India?

It is very easy for Indian residents to invest directly in An2 Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the An2 Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for An2 Therapeutics or ANTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of An2 Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of An2 Therapeutics shares which would translate to 0.703 fractional shares of An2 Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like An2 Therapeutics, in just a few clicks!

Returns in An2 Therapeutics (ANTX) for Indian investors in Rupees

The An2 Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

An2 Therapeutics investment value today

Current value as on today

₹47,504

Returns

₹52,496

(-52.5%)

Returns from An2 Therapeutics Stock

₹53,668 (-53.67%)

Dollar Returns

₹1,172 (+1.17%)

Indian investors sentiment towards An2 Therapeutics (ANTX)

100%

Period: Apr 3, 2025 to May 3, 2025. Change in 30 Days versus previous period

Search interest for An2 Therapeutics Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in An2 Therapeutics

BML Capital Management LLC
19.10%
Almitas Capital LLC
4.36%
Vanguard Group Inc
3.44%
Pfizer Inc
2.38%
Renaissance Technologies Corp
1.93%
Peapod Lane Capital LLC
1.92%

Analyst Recommendation on An2 Therapeutics

Rating

Trend

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for An2 Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on An2 Therapeutics Stock (ANTX)

What analysts predicted

Upside of 122.23%

Target:

$2.67

Current:

$1.20

Insights on An2 Therapeutics Stock (Ticker Symbol: ANTX)

Price Movement
In the last 3 years, ANTX stock has moved down by -93.3%
ANTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.2% return, outperforming this stock by 123.3%
ANTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 80.7% return, outperforming this stock by 174.0%

An2 Therapeutics Technicals Summary

Sell

Neutral

Buy

An2 Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

An2 Therapeutics (ANTX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
An2 Therapeutics, Inc.	-5.51%	11.11%	-53.67%	-93.42%	-92.21%
Regeneron Pharmaceuticals, Inc.	5.59%	-26.95%	-36.84%	-5.3%	5.42%
Beone Medicines Ltd	7.16%	23.32%	57.31%	60.26%	78.11%
Vertex Pharmaceuticals Incorporated	5.59%	6.0%	24.51%	88.14%	84.02%
Alnylam Pharmaceuticals, Inc.	9.96%	-3.97%	71.43%	89.58%	83.55%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
An2 Therapeutics, Inc.	NA	NA	NA	-0.95	-0.5	-0.3	NA	2.74
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.91	39.38	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.1	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.44	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
An2 Therapeutics, Inc.	Buy	$37.3M	-92.21%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.42%	15.94	31.07%
Beone Medicines Ltd	NA	$28.2B	78.11%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.2B	84.02%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	83.55%	NA	-12.37%

About An2 Therapeutics

AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis. It also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials; and has various research programs targeting the development of novel compounds in oncology and infectious disease based on its boron chemistry platform. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize compounds and products, including epetraborole for the treatment, diagnosis, or prevention of various human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize compounds and products comprising epetraborole in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Organization	An2 Therapeutics
Employees	22
CEO	Mr. Eric E. Easom
Industry	Services

Management People of An2 Therapeutics

Name	Title
Mr. Eric E. Easom	Co-Founder, CEO, President & Chairman of the Board
Mr. Joseph S. Zakrzewski	Co-Founder & Independent Chairman of the Board
Ms. Lucy O. Day CPA	CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Joshua Eizen J.D.	Chief Legal Officer, COO & Corporate Secretary
Dr. George Harrison Talbot FACP, M.D.	Co-Founder & Senior Clinical Advisor
Dr. Michael R. K. Alley Ph.D.	Co-Founder, Senior VP of Research Fellow & Head of Biology
Dr. Sanjay Chanda Ph.D.	Chief Development Officer
Dr. Stephen David Prior Ph.D.	Chief Strategy Officer
Mr. Vince Hernandez	Senior VP of Research & Head of Chemistry

Important FAQs about investing in ANTX Stock from India :

What is An2 Therapeutics share price today?

An2 Therapeutics share price today stands at $1.20, Open: $1.19 ; Previous Close: $1.24 ; High: $1.22 ; Low: $1.19 ; 52 Week High: $3.07 ; 52 Week Low: $0.87.

The stock opens at $1.19, after a previous close of $1.24. The stock reached a daily high of $1.22 and a low of $1.19, with a 52-week high of $3.07 and a 52-week low of $0.87.

Can Indians buy An2 Therapeutics shares?

Yes, Indians can invest in the An2 Therapeutics (ANTX) from India.

With INDmoney, you can buy An2 Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy An2 Therapeutics at zero transaction cost.

How can I buy An2 Therapeutics shares from India?

It is very easy to buy An2 Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of An2 Therapeutics (ANTX) be purchased?

Yes, you can buy fractional shares of An2 Therapeutics with INDmoney app.

What are the documents required to start investing in An2 Therapeutics stocks?

To start investing in An2 Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.